CAS 431040-19-6

Fórmula: C18H13N7S

InChI: InChI=1S/C18H13N7S/c1-12-21-7-8-25(12)17-16(14-4-2-3-13(9-14)10-19)24-18(26-17)23-15-11-20-5-6-22-15/h2-9,11H,1H3,(H,22,23,24)

Clave InChI: YNGFNKUXMJZNCR-UHFFFAOYSA-N

SMILES: CC1=NC=CN1C2=C(N=C(S2)NC3=NC=CN=C3)C4=CC=CC(=C4)C#N

Adenosine Antagonist-1

CAS: 431040-19-6

Ref: IN-DA01EOOL

Adenosine antagonist-1

CAS: 431040-19-6

Adenosine antagonist-1

Fórmula: C₁₈H₁₃N₇S

Pureza: ≥98%

Peso molecular: 359.41

Ref: 54-BUP11987

Adenosine antagonist-1

CAS: 431040-19-6

3-(5-(2-Methyl-1H-imidazol-1-yl)-2-(pyrazin-2-ylamino)thiazol-4-yl)benzonitrile

Fórmula: C₁₈H₁₃N₇S

Pureza: 98%

Peso molecular: 359.41

Ref: IN-DG00792379

Adenosine antagonist-1

CAS: 431040-19-6

Adenosine antagonist-1 is a substance that binds to the adenosine receptor. It has been shown that this substance inhibits the binding of adenosine to its receptors, which blocks the effect of endogenous adenosine and prevents the transmission of pain signals in animals. Adenosine antagonist-1 also has an effect on neurotransmission and blood pressure. In addition, it has been shown that this substance does not affect glutamate release or produce locomotor activity in animals.

Fórmula: C₁₈H₁₃N₇S

Pureza: Min. 95%

Peso molecular: 359.4 g/mol

Ref: 3D-GSA04019

Adenosine antagonist-1

CAS: 431040-19-6

Adenosine antagonist-1 acts as an adenosine A3 receptor (AA3R) antagonist.

Fórmula: C₁₈H₁₃N₇S

Pureza: 99.73% - 99.95%

Forma y color: White Solid

Peso molecular: 359.41

Ref: TM-T10248